Are you curious about how psychedelic medicine works and not sure where to start? Join Robin Carhart-Harris, Ralph Metzner Distinguished Professor of Neurology & Psychiatry at UCSF and the Director of the Carhart-Harris lab to explore a multi-level view of the brain science of classic psychedelic drugs. These specific types of drugs share the property of activating the serotonin 2A receptor which is responsible for various physiological and psychological processes. Dr. Carhart-Harris will review recent trial and imaging results from a double-blind randomized controlled trial of psilocybin therapy for the treatment of depression.